ES8609286A1 - Un metodo para preparar un compuesto de morfolinol - Google Patents

Un metodo para preparar un compuesto de morfolinol

Info

Publication number
ES8609286A1
ES8609286A1 ES544862A ES544862A ES8609286A1 ES 8609286 A1 ES8609286 A1 ES 8609286A1 ES 544862 A ES544862 A ES 544862A ES 544862 A ES544862 A ES 544862A ES 8609286 A1 ES8609286 A1 ES 8609286A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compounds
minimal brain
heterocyclic pharmaceutical
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES544862A
Other languages
English (en)
Spanish (es)
Other versions
ES544862A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES8609286A1 publication Critical patent/ES8609286A1/es
Publication of ES544862A0 publication Critical patent/ES544862A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES544862A 1984-07-05 1985-07-04 Un metodo para preparar un compuesto de morfolinol Expired ES8609286A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848417170A GB8417170D0 (en) 1984-07-05 1984-07-05 Heterocyclic pharmaceutical compounds

Publications (2)

Publication Number Publication Date
ES8609286A1 true ES8609286A1 (es) 1986-07-16
ES544862A0 ES544862A0 (es) 1986-07-16

Family

ID=10563453

Family Applications (1)

Application Number Title Priority Date Filing Date
ES544862A Expired ES8609286A1 (es) 1984-07-05 1985-07-04 Un metodo para preparar un compuesto de morfolinol

Country Status (12)

Country Link
EP (1) EP0170430A1 (enExample)
JP (1) JPS6124578A (enExample)
KR (1) KR860001083A (enExample)
AU (1) AU4459585A (enExample)
DK (1) DK307385A (enExample)
ES (1) ES8609286A1 (enExample)
FI (1) FI852657A7 (enExample)
GB (1) GB8417170D0 (enExample)
GR (1) GR851645B (enExample)
HU (1) HUT39437A (enExample)
IL (1) IL75720A0 (enExample)
ZA (1) ZA855072B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8924528D0 (en) * 1989-10-31 1989-12-20 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
US7098206B2 (en) 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
BR9907203A (pt) 1998-01-21 2000-10-17 Glaxo Group Ltd "composto, composições farmacêuticas, uso de um composto, e, processo de tratametno de depressão, distúrbio de hiperatividade por deficiência de atenção (adhd), obesidade, enxaqueca, dor, disfunção sexual, doença de parkinson, doença de alzeheimer, ou vìcio de cocaìna ou de produtos contendo nicotina (especialmente tabaco) em um indivìduo animal ou humano. "
US6998400B2 (en) 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US7241805B2 (en) 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
KR101014438B1 (ko) * 2008-09-26 2011-02-14 동아제약주식회사 탁산 유도체의 제조방법
CA2800220C (en) 2010-05-21 2019-04-30 Research Triangle Institute Phenylmorpholines and analogues thereof
CA2800219C (en) 2010-05-21 2019-03-12 Research Triangle Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
JPS6124578A (ja) 1986-02-03
GB8417170D0 (en) 1984-08-08
EP0170430A1 (en) 1986-02-05
KR860001083A (ko) 1986-02-22
DK307385A (da) 1986-01-06
ES544862A0 (es) 1986-07-16
FI852657L (fi) 1986-01-06
HUT39437A (en) 1986-09-29
AU4459585A (en) 1986-01-09
FI852657A7 (fi) 1986-01-06
FI852657A0 (fi) 1985-07-04
DK307385D0 (da) 1985-07-04
GR851645B (enExample) 1985-11-26
IL75720A0 (en) 1985-11-29
ZA855072B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
ES8407049A1 (es) Un procedimiento para la preparacion de compuestos biciclicos.
IT8220274A0 (it) Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica.
ES296226Y (es) Capsula de voina dura para la administracion de compuestos farmaceuticamente activos.
AT323181B (de) Verfahren zur herstellung von neuen pyrrolo (3,4-b) pyrazinderivaten sowie von deren säureadditionssalzen
ES521041A0 (es) Procedimiento para la preparacion de nuevos derivados de aminoacidos biciclicos.
ES520802A0 (es) Procedimiento para la preparacion de nuevos derivados de aminoacidos biciclicos.
IL69420A0 (en) Homocholanic acid esters for use in the synthesis of 26,27-radiolabeled derivatives of vitamin d
FI885518A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5-dihydro-4-okso-5-isopropyyli-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
AR242560A1 (es) Un procedimiento para producir derivados de acidos 1-amidin-piperidin-alcanoicos y sus sales farmaceuticamente aceptables.
HUT38255A (en) Process for preparing pharmaceutical compositions containing pyrimido-pyrimidines and o-acetyl-salicylic acid resp. pharmaceutically acceptable salts thereof
ES8406461A1 (es) Procedimiento para la obtencion de benzofuranonas
ES551435A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina
YU126573A (en) Process for preparing new mono - and siesters of 2,5-dihydroxy benzene sulfonic acid
CA1026373A (en) Process for the manufacture of sulphonic acid fluorides
PT65521B (de) "n-te trahydrofurfuryl-noroxymorphone deren saureadditionssalze diese enthaltende arzneimittel sowie verfahren zu ihrer herstellung
ES8502435A1 (es) Un metodo para preparar 2(1h)-piridinonas
NZ182681A (en) 2-(9-substitutedpurin-6-ylamino or 1-substituted pyrazolo (3,4-d)-pyrimidin-4-ylamino)benzoic acid derivatives
PT88116A (pt) Process for preparing naphthalenepropionic acid derivatives useful as anti-inflammatory/antiallergic agents
MX4842E (es) Procedimiento para la preparacion de derivados de acido 4-fenoxi-(-fenoxialcancarbocilico substituidos en el nucleo
DK134229B (da) Analogifremgangsmåde til fremstilling af 1-substituerede 1,4-benzodiazepinderivater eller farmaceutisk anvendelige syreadditionssalte deraf.
ES522976A0 (es) "procedimiento para la obtencion de nuevos derivados de la 4-aril-2-metil-1,2,3,4-tetrahidro-isoquinolina y de sus sales de adicion acida farmaceuticamente aceptables"
DE3482324D1 (de) Verbindung mit entzuendungshemmender wirkung, verfahren zu ihrer herstellung und pharmazeutische praeparate die sie enthalten.
FI844374A7 (fi) Menetelmä farmaseuttisesti aktiivisten heterosyklisten yhdisteiden valmistamiseksi.
FI854985A7 (fi) Menetelmä farmaseuttisesti aktiivisten N-substituoitujen atsiridiini-2-karboksyylihappojohdannaisten valmistamiseksi.
ATE49754T1 (de) Neue imidazolylverbindungen und verfahren zu ihrer herstellung.